
Golam M. Shameem
Examiner (ID: 11001, Phone: (571)272-0706 , Office: P/1626 )
| Most Active Art Unit | 1621 |
| Art Unit(s) | 1621, 1622, 1626 |
| Total Applications | 3199 |
| Issued Applications | 2366 |
| Pending Applications | 304 |
| Abandoned Applications | 576 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15928107
[patent_doc_number] => 20200155687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => METHODS OF TREATMENT USING AN AMPHETAMINE PRODRUG
[patent_app_type] => utility
[patent_app_number] => 16/603936
[patent_app_country] => US
[patent_app_date] => 2018-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18453
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -66
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16603936
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/603936 | METHODS OF TREATMENT USING AN AMPHETAMINE PRODRUG | Apr 9, 2018 | Abandoned |
Array
(
[id] => 17376975
[patent_doc_number] => 11234964
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-01
[patent_title] => Use of melatonin for the treatment of tumors
[patent_app_type] => utility
[patent_app_number] => 16/498825
[patent_app_country] => US
[patent_app_date] => 2018-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 7155
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498825
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/498825 | Use of melatonin for the treatment of tumors | Apr 1, 2018 | Issued |
Array
(
[id] => 13328357
[patent_doc_number] => 20180215716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => AROMATIC COMPOUND PRODUCTION METHOD
[patent_app_type] => utility
[patent_app_number] => 15/940426
[patent_app_country] => US
[patent_app_date] => 2018-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4394
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 200
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15940426
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/940426 | Aromatic compound production method | Mar 28, 2018 | Issued |
Array
(
[id] => 17162916
[patent_doc_number] => 11149003
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-19
[patent_title] => Resolution of racemic beta-aminosulfone compounds
[patent_app_type] => utility
[patent_app_number] => 16/500671
[patent_app_country] => US
[patent_app_date] => 2018-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5939
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500671
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500671 | Resolution of racemic beta-aminosulfone compounds | Mar 27, 2018 | Issued |
Array
(
[id] => 13812553
[patent_doc_number] => 10183034
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-22
[patent_title] => Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives
[patent_app_type] => utility
[patent_app_number] => 15/935782
[patent_app_country] => US
[patent_app_date] => 2018-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 27926
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15935782
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/935782 | Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives | Mar 25, 2018 | Issued |
Array
(
[id] => 13761091
[patent_doc_number] => 10172874
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-08
[patent_title] => Pharmaceutical compositions comprising cyclic boronic acid ester derivatives
[patent_app_type] => utility
[patent_app_number] => 15/935862
[patent_app_country] => US
[patent_app_date] => 2018-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 27937
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15935862
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/935862 | Pharmaceutical compositions comprising cyclic boronic acid ester derivatives | Mar 25, 2018 | Issued |
Array
(
[id] => 14258771
[patent_doc_number] => 10278929
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-07
[patent_title] => Identification of stabilizers of multimeric proteins
[patent_app_type] => utility
[patent_app_number] => 15/936159
[patent_app_country] => US
[patent_app_date] => 2018-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 32
[patent_no_of_words] => 20660
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15936159
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/936159 | Identification of stabilizers of multimeric proteins | Mar 25, 2018 | Issued |
Array
(
[id] => 13314091
[patent_doc_number] => 20180208582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => COMPOUNDS, COMPOSITIONS, AND METHODS
[patent_app_type] => utility
[patent_app_number] => 15/927920
[patent_app_country] => US
[patent_app_date] => 2018-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28144
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15927920
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/927920 | Compounds, compositions, and methods | Mar 20, 2018 | Issued |
Array
(
[id] => 15363337
[patent_doc_number] => 20200017433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => Modulators of Liver Receptor Homologue 1 (LRH-1) and Uses
[patent_app_type] => utility
[patent_app_number] => 16/495092
[patent_app_country] => US
[patent_app_date] => 2018-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30740
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 452
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16495092
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/495092 | Modulators of liver receptor homologue 1 (LRH-1) and uses | Mar 15, 2018 | Issued |
Array
(
[id] => 13944633
[patent_doc_number] => 10208072
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-19
[patent_title] => Universal enzyme responsive linker for assembling ligands on DNA functionalized nanomaterials
[patent_app_type] => utility
[patent_app_number] => 15/917911
[patent_app_country] => US
[patent_app_date] => 2018-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 8378
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15917911
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/917911 | Universal enzyme responsive linker for assembling ligands on DNA functionalized nanomaterials | Mar 11, 2018 | Issued |
Array
(
[id] => 15054767
[patent_doc_number] => 10457672
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => g-diketones as Wnt/b-catenin signaling pathway activators
[patent_app_type] => utility
[patent_app_number] => 15/918086
[patent_app_country] => US
[patent_app_date] => 2018-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54764
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15918086
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/918086 | g-diketones as Wnt/b-catenin signaling pathway activators | Mar 11, 2018 | Issued |
Array
(
[id] => 15553313
[patent_doc_number] => 20200061068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives
[patent_app_type] => utility
[patent_app_number] => 16/493018
[patent_app_country] => US
[patent_app_date] => 2018-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11960
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16493018
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/493018 | Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives | Mar 11, 2018 | Issued |
Array
(
[id] => 13402351
[patent_doc_number] => 20180252718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => BIOTINYLATED LUMINESCENT PROBE
[patent_app_type] => utility
[patent_app_number] => 15/909020
[patent_app_country] => US
[patent_app_date] => 2018-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15909020
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/909020 | Biotinylated luminescent probe | Feb 28, 2018 | Issued |
Array
(
[id] => 13444025
[patent_doc_number] => 20180273555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => METHOD FOR PREPARING RACEMIC OR OPTICALLY ACTIVED D- OR L-A-GLYCEROPHOSPHORYLCHOLINE SOLIDS
[patent_app_type] => utility
[patent_app_number] => 15/907352
[patent_app_country] => US
[patent_app_date] => 2018-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3960
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15907352
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/907352 | Method for preparing racemic or optically actived D- or L-A-glycerophosphorylcholine solids | Feb 27, 2018 | Issued |
Array
(
[id] => 16590472
[patent_doc_number] => 10899722
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-26
[patent_title] => Process for the preparation of fluoroalkylnitriles and the corresponding fluoroalkyltetrazoles
[patent_app_type] => utility
[patent_app_number] => 16/488289
[patent_app_country] => US
[patent_app_date] => 2018-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4719
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16488289
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/488289 | Process for the preparation of fluoroalkylnitriles and the corresponding fluoroalkyltetrazoles | Feb 21, 2018 | Issued |
Array
(
[id] => 16491118
[patent_doc_number] => 10857136
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => Compounds for use in the prevention and/or treatment of non-alcoholic fat liver disease and non-alcoholic steatohepatitis
[patent_app_type] => utility
[patent_app_number] => 16/490670
[patent_app_country] => US
[patent_app_date] => 2018-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 21
[patent_no_of_words] => 11763
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16490670
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/490670 | Compounds for use in the prevention and/or treatment of non-alcoholic fat liver disease and non-alcoholic steatohepatitis | Feb 18, 2018 | Issued |
Array
(
[id] => 13357239
[patent_doc_number] => 20180230159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE
[patent_app_type] => utility
[patent_app_number] => 15/891585
[patent_app_country] => US
[patent_app_date] => 2018-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15891585
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/891585 | DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE | Feb 7, 2018 | Abandoned |
Array
(
[id] => 14246031
[patent_doc_number] => 10273207
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-30
[patent_title] => Covalent inhibitors of kras G12C
[patent_app_type] => utility
[patent_app_number] => 15/891304
[patent_app_country] => US
[patent_app_date] => 2018-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 52815
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 283
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15891304
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/891304 | Covalent inhibitors of kras G12C | Feb 6, 2018 | Issued |
Array
(
[id] => 12790612
[patent_doc_number] => 20180155373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => Cysteine-Modifying Substrate Analogue Inhibitors of Ribose 5-Phosphate Isomerase for Parasitic Diseases, Along with Methods of Their Formation and Use
[patent_app_type] => utility
[patent_app_number] => 15/888158
[patent_app_country] => US
[patent_app_date] => 2018-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15888158
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/888158 | Cysteine-modifying substrate analogue inhibitors of ribose 5-phosphate isomerase for parasitic diseases, along with methods of their formation and use | Feb 4, 2018 | Issued |
Array
(
[id] => 12746449
[patent_doc_number] => 20180140650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => ISOLATION OF OMEGA-7 FATTY ACID ETHYL ESTERS FROM NATURAL OILS
[patent_app_type] => utility
[patent_app_number] => 15/875098
[patent_app_country] => US
[patent_app_date] => 2018-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7176
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15875098
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/875098 | Isolation of Omega-7 fatty acid ethyl esters from natural oils | Jan 18, 2018 | Issued |